1 / 16

Central Venous Catheter Market Analysis | CMI

Read here the latest updates on the Central Venous Catheter Market Analysis published by CMI team

Shweta2707
Télécharger la présentation

Central Venous Catheter Market Analysis | CMI

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. CENTRAL VENOUS CATHETER MARKET ANALYSIS • Central Venous Catheter Market, By Product Type (Tunneled Catheters, Non-Tunneled Catheters), By Property (Anti-Microbial Catheter, Non- Anti-Microbial Catheter), By Design (Single Lumen, Double Lumen, Multi Lumen), By Composition (Polyurethane, Polyurethane/Polycarbonate, Silicone), By End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics & Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027 • The global central venous catheter market is estimated to account for US$ 778.0 Mn in terms of value in 2019 and is expected to reach US$ 1,164.5 Mn by the end of 2027.

  3. Global Central Venous Catheter Market: Drivers • Increasing prevalence of diseases that require long-term therapies such as cancer (chemotherapy) and end stage renal disease (dialysis) is expected to fuel growth of the U.S. Central Venous Catheter Market. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018. • Moreover, high incidence of renal diseases is also expected to aid in the market growth. For instance, according to European Renal Association – European Dialysis and Transplant Association’s data in 2018, over 850 million people worldwide have some form of kidney disease.

  4. Statistics • Asia Pacific region held dominant position in the global central venous catheter market in 2018, accounting for 30.1% share in terms of value, followed by North America.

  5. Global Central Venous Catheter Market: Restraints • High cost of antimicrobial-coated catheters is expected to hinder growth of the global central venous catheter market. The average cost of an antimicrobial coated catheter is four times more than the cost of normal catheters without coating. This may lead to high preference for non-antimicrobial coated catheters to minimize the cost of surgery. • Moreover, there are significant risks and complications associated with central venous catheterization procedures such as bleeding, damage to blood vessel, arterial puncture, hematoma, and pneumothorax. Use of central venous catheters can also lead to infection at the insertion site of the catheter, contamination of the catheter, and haematogenous seeding of the catheter. This in turn is expected to hinder growth of the market.

  6. Global Central Venous Catheter Market: Opportunities • Introduction of catheters with antimicrobial protection is expected to offer lucrative growth opportunities for players in the global central venous catheters market. For instance, in July 2019, researchers from Nottingham University reported development of a Bactigon, a new family of biomaterials that have a major impact against antimicrobial resistance (AMR). • Major regulatory bodies are focused on offering guidance for product approval, which is expected to offer lucrative growth opportunities for players in the market. For instance, in January 2020, the U.S. FDA released draft guidance detailing the information device-makers should include in 510(k) submissions of catheter-based devices intended to treat peripheral vasculature lesions. • Product type segment in the global central venous catheter market is estimated to be valued at US$ 778.0 Mn in 2019 and is expected to reach US$ 1,164.5 Mn by 2026 at a CAGR of 5.1% during the forecast period.

  7. Market Trends/Key Takeaways • The use of evidence-based care bundles reinforced by real-time feedback has led to significant decrease in rate of catheter-related bloodstream infection in the intensive care unit. This in turn is expected to aid in growth of the market. • The use of central venous catheter in administering chemotherapy drugs has increased significantly. This is owing to various benefits of central venous catheters such it helps to avoid serious damage to skin and muscle tissue from drugs that are capable of such adverse effects if they leak outside a vein.

  8. Regulations • U.S. • The U.S. FDA authorized use of mono, duo, trio, Quattro lumen central venous catheters, as they fall under class II • Therefore, companies do not require a premarket approval before commercializing the device for central access procedures. However, a 510K approval is still necessary • According to the Federal Food, Drug and Cosmetic Act (Act), central venous catheters comes under class II and do not require approval i.e. premarket approval application (PMA). However the device is marketed under general controls provisions of the Act. which includes requirements for annual registration, listing of devices, good manufacturing practice, labeling and prohibitions against misbranding and adulteration.

  9. Value Chain Analysis

  10. Global Central Venous Catheter Market: Competitive Landscape • Major players operating in the global central venous catheter market include, AngioDynamics, C.R. Bard, Teleflex Incorporated, B. Braun Melsungen AG, Kimal, Comed B.V., Medtronic Plc., Smiths Medical, Inc., and Vygon Group.

  11. Global Central Venous Catheter Market: Key Developments • Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in October 2019, Vygon Group acquired Pilot, an Italy-based ECG central venous catheter tip location and navigation devices manufacturer. • Major players in the market are also focused on adopting various marketing strategies to enhance their market share. For instance, in November 2019, Teleflex Incorporated showcased its Interventional product portfolio including the MANTA Vascular Closure Device and Langston Dual Lumen Catheters at the PCR London Valves held in London.

  12. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Reference : https://www.coherentmarketinsights.com/market-insight/central-venous-catheter-market-2400

  13. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  14. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  15. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related